The American Society of Addiction Medicine and the American Medical Association yesterday released an issue brief on an alternative payment model for medication-assisted therapy, and seek physician practices and insurers interested in pilot testing the model for patients with opioid use disorder. “While we know that a combination of medication and psychosocial support systems is the evidence-based standard for treatment, we continue to find that patients are not able to access treatment due to limited or non-existent insurance coverage,” said Shawn Ryan, M.D., chair of the AMA-ASAM working group that developed the framework for the model, called Patient-Centered Opioid Addiction Treatment (P-COAT). “We hope that today’s announcement will begin a national conversation with insurers and policymakers about what it takes for successful treatment and recovery.” AHA also is developing a strategy to treat substance use disorders as part of its work to advance new payment models, which includes working with the Alliance for Recovery-centered Addiction Health Services to design a system of care for SUD screening, treatment and recovery that incentivizes recovery, not relapse, for alcohol and opioid use disorders. AHA members participating in the Alliance, which expects to release more information on its model this summer, include Carroll Hospital Center in Westminster, MD; Intermountain Healthcare in Salt Lake City; Johns Hopkins Medicine in Baltimore; Partners HealthCare in Boston; and UCSF Health in San Francisco.

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on…
Headline
The AHA’s Society for Health Care Strategy & Market Development Oct. 21 announced Dennis S. Jolley, system vice president of strategy and planning at UW…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…
Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
Ashley Thompson, AHA senior vice president of public policy analysis and development, participated in a panel discussion during Modern Healthcare's Leadership…